Vega Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2018-01-01
- Employees
- 11
- Market Cap
- -
Study of VGA039 in Healthy Volunteers and Patients with Von Willebrand Disease (VIVID)
- First Posted Date
- 2023-03-20
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Vega Therapeutics, Inc
- Target Recruit Count
- 116
- Registration Number
- NCT05776069
- Locations
- 🇺🇸
Hemophilia of Georgia Center for Bleeding & Clotting Disorders of Emory, Atlanta, Georgia, United States
🇺🇸Washington Center for Bleeding Disorders, Seattle, Washington, United States
🇦🇺Royal Brisbane & Women's Hospital, Queensland Haemophilia Centre, Herston, Queenland, Australia
© Copyright 2025. All Rights Reserved by MedPath